| Symbol |
Name |
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5
|
|
ADAMTS9
|
ADAM metallopeptidase with thrombospondin type 1 motif, 9
|
|
ADM
|
adrenomedullin
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADORA3
|
adenosine A3 receptor
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDOA
|
aldolase A, fructose-bisphosphate
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
AMBP
|
alpha-1-microglobulin/bikunin precursor
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
APOA1
|
apolipoprotein A-I
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
AREG
|
amphiregulin
|
|
ARRB1
|
arrestin, beta 1
|
|
ARRB2
|
arrestin, beta 2
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BGN
|
biglycan
|
|
C3
|
complement component 3
|
|
C3AR1
|
complement component 3a receptor 1
|
|
C5
|
complement component 5
|
|
C5AR1
|
complement component 5a receptor 1
|
|
CADM1
|
cell adhesion molecule 1
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase
|
|
CCL1
|
chemokine (C-C motif) ligand 1
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR4
|
chemokine (C-C motif) receptor 4
|
|
CCR8
|
chemokine (C-C motif) receptor 8
|
|
CD14
|
CD14 molecule
|
|
CD160
|
CD160 molecule
|
|
CD1A
|
CD1a molecule
|
|
CD200R1
|
CD200 receptor 1
|
|
CD226
|
CD226 molecule
|
|
CD300A
|
CD300a molecule
|
|
CD300C
|
CD300c molecule
|
|
CD34
|
CD34 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD52
|
CD52 molecule
|
|
CD63
|
CD63 molecule
|
|
CD72
|
CD72 molecule
|
|
CD84
|
CD84 molecule
|
|
CD9
|
CD9 molecule
|
|
CHIC2
|
cysteine-rich hydrophobic domain 2
|
|
CLEC11A
|
C-type lectin domain family 11, member A
|
|
CLEC4E
|
C-type lectin domain family 4, member E
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
|
CMA1
|
chymase 1, mast cell
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CPA3
|
carboxypeptidase A3 (mast cell)
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSB
|
cathepsin B
|
|
CTSC
|
cathepsin C
|
|
CTSL
|
cathepsin L
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1
|
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
|
CYSLTR2
|
cysteinyl leukotriene receptor 2
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DCN
|
decorin
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEFB4A
|
defensin, beta 4A
|
|
DYNLL1
|
dynein, light chain, LC8-type 1
|
|
EFHD2
|
EF-hand domain family, member D2
|
|
EGFR
|
epidermal growth factor receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
FAS
|
Fas cell surface death receptor
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FES
|
FES proto-oncogene, tyrosine kinase
|
|
FGF12
|
fibroblast growth factor 12
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FPR2
|
formyl peptide receptor 2
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GNAI3
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
GZMK
|
granzyme K (granzyme 3; tryptase II)
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HMGB1
|
high mobility group box 1
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HPGDS
|
hematopoietic prostaglandin D synthase
|
|
HPSE
|
heparanase
|
|
HRH2
|
histamine receptor H2
|
|
HRH3
|
histamine receptor H3
|
|
HRH4
|
histamine receptor H4
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNG
|
interferon, gamma
|
|
IFNL1
|
interferon, lambda 1
|
|
IGES
|
immunoglobulin E concentration, serum
|
|
IL10
|
interleukin 10
|
|
IL13
|
interleukin 13
|
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
|
IL16
|
interleukin 16
|
|
IL17A
|
interleukin 17A
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL22
|
interleukin 22
|
|
IL24
|
interleukin 24
|
|
IL27
|
interleukin 27
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL31
|
interleukin 31
|
|
IL33
|
interleukin 33
|
|
IL33R
|
interleukin 33 receptor
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5
|
interleukin 5
|
|
IL5RA
|
interleukin 5 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
IL9
|
interleukin 9
|
|
INHA
|
inhibin, alpha
|
|
INHBA
|
inhibin, beta A
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KDR
|
kinase insert domain receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
LAMA3
|
laminin, alpha 3
|
|
LAMA5
|
laminin, alpha 5
|
|
LAT
|
linker for activation of T cells
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LILRA2
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LILRB3
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3
|
|
LILRB4
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
|
|
LILRB5
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5
|
|
LPAR5
|
lysophosphatidic acid receptor 5
|
|
LTB4R
|
leukotriene B4 receptor
|
|
LTB4R2
|
leukotriene B4 receptor 2
|
|
LTC4S
|
leukotriene C4 synthase
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MATK
|
megakaryocyte-associated tyrosine kinase
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MILR1
|
mast cell immunoglobulin-like receptor 1
|
|
MIR132
|
microRNA 132
|
|
MIR143
|
microRNA 143
|
|
MIR146A
|
microRNA 146a
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MRGPRX2
|
MAS-related GPR, member X2
|
|
MS4A2
|
membrane-spanning 4-domains, subfamily A, member 2
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
NCS1
|
neuronal calcium sensor 1
|
|
NDST1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NGFR
|
nerve growth factor receptor
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOX1
|
NADPH oxidase 1
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NSF
|
N-ethylmaleimide-sensitive factor
|
|
OSM
|
oncostatin M
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6
|
|
PARK7
|
parkinson protein 7
|
|
PATZ1
|
POZ (BTB) and AT hook containing zinc finger 1
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PF4
|
platelet factor 4
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLD2
|
phospholipase D2
|
|
PLK1
|
polo-like kinase 1
|
|
PLSCR1
|
phospholipid scramblase 1
|
|
PLTP
|
phospholipid transfer protein
|
|
POMC
|
proopiomelanocortin
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
|
PRG2
|
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCH
|
protein kinase C, eta
|
|
PTAFR
|
platelet-activating factor receptor
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDR
|
prostaglandin D2 receptor (DP)
|
|
PTGDR2
|
prostaglandin D2 receptor 2
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
RABGEF1
|
RAB guanine nucleotide exchange factor (GEF) 1
|
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated)
|
|
RASGRP4
|
RAS guanyl releasing protein 4
|
|
REN
|
renin
|
|
RGS13
|
regulator of G-protein signaling 13
|
|
RIN3
|
Ras and Rab interactor 3
|
|
RLN2
|
relaxin 2
|
|
RORC
|
RAR-related orphan receptor C
|
|
S100A12
|
S100 calcium binding protein A12
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S1PR2
|
sphingosine-1-phosphate receptor 2
|
|
SELE
|
selectin E
|
|
SELPLG
|
selectin P ligand
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4
|
|
SERPINB6
|
serpin peptidase inhibitor, clade B (ovalbumin), member 6
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SIGLEC7
|
sialic acid binding Ig-like lectin 7
|
|
SIGLEC8
|
sialic acid binding Ig-like lectin 8
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC30A4
|
solute carrier family 30 (zinc transporter), member 4
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLC9A3R2
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2
|
|
SNAP23
|
synaptosomal-associated protein, 23kDa
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SPG21
|
spastic paraplegia 21 (autosomal recessive, Mast syndrome)
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPHK2
|
sphingosine kinase 2
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STX3
|
syntaxin 3
|
|
STXBP1
|
syntaxin binding protein 1
|
|
STXBP2
|
syntaxin binding protein 2
|
|
SYK
|
spleen tyrosine kinase
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACR1
|
tachykinin receptor 1
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
THBD
|
thrombomodulin
|
|
THPO
|
thrombopoietin
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNFSF8
|
tumor necrosis factor (ligand) superfamily, member 8
|
|
TP53
|
tumor protein p53
|
|
TPSAB1
|
tryptase alpha/beta 1
|
|
TPT1
|
tumor protein, translationally-controlled 1
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
UCN
|
urocortin
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
|
USF1
|
upstream transcription factor 1
|
|
VAMP7
|
vesicle-associated membrane protein 7
|
|
VAMP8
|
vesicle-associated membrane protein 8
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VSTM1
|
V-set and transmembrane domain containing 1
|
|
YKT6
|
YKT6 v-SNARE homolog (S. cerevisiae)
|
